Franklin Lakes, New Jersey-based Becton, Dickinson (BD) in partnership with the Oakbrook, Illinois-headquartered Joint Commission International (JCI) launched a new patient safety program for hospitals, called Preventing Risks of Infections and Medication Errors in Intraveneous Therapy (PRIME) in India. PRIME is a programmatic approach toward patient safety which will be implemented over a six-month duration, composed of goal-setting, progress review, tconsultations with experts, and scientific updates through webinars. Hospitals will be certified upon successful completion of the program.
Aimed at addressing the two critical challenges in a hospital setting – infection prevention and medication safety – PRIME is developed by Joint Commission International for patient safety, with sponsorship by BD, and has been launched across South Korea, Japan, Malaysia, Thailand, Indonesia, Philippines and Vietnam, in addition to India.
At the event, Pavan Mocherla, managing director, BD-India & South Asia said, “Increasingly, healthcare facilities across India are working to upgrade quality standards to achieve a future of better patient outcomes, increased patient safety and cost efficiency in healthcare systems. Through this hallmark program for hospitals, BD will be able to help enhance patient and clinical outcomes by eliminating complications and improving safety for patients and providers leading to accessing better care.”
Last updated: December 26th, 2025
